|
CN110612353A
(zh)
|
2017-03-03 |
2019-12-24 |
加利福尼亚大学董事会 |
经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
|
|
KR20200074104A
(ko)
|
2017-10-04 |
2020-06-24 |
더 브로드 인스티튜트, 인코퍼레이티드 |
표적화된 핵산 편집을 위한 시스템, 방법, 및 조성물
|
|
WO2019084062A1
(en)
*
|
2017-10-23 |
2019-05-02 |
The Broad Institute, Inc. |
SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITION
|
|
US20230193242A1
(en)
*
|
2017-12-22 |
2023-06-22 |
The Broad Institute, Inc. |
Cas12b systems, methods, and compositions for targeted dna base editing
|
|
US12391685B2
(en)
|
2018-08-20 |
2025-08-19 |
The Broad Institute, Inc. |
Inhibitors of RNA-guided nuclease target binding and uses thereof
|
|
WO2020041384A1
(en)
|
2018-08-20 |
2020-02-27 |
The Broad Institute, Inc. |
3-phenyl-2-cyano-azetidine derivatives, inhibitors of rna-guided nuclease activity
|
|
US20210403907A1
(en)
|
2018-09-18 |
2021-12-30 |
Vnv Newco Inc. |
Arc-based capsids and uses thereof
|
|
EP3852813A4
(en)
|
2018-09-18 |
2022-06-22 |
VNV Newco Inc. |
ARC-BASED CAPSIDS AND THEIR USES
|
|
WO2020081730A2
(en)
|
2018-10-16 |
2020-04-23 |
Massachusetts Institute Of Technology |
Methods and compositions for modulating microenvironment
|
|
US12258594B2
(en)
|
2018-12-05 |
2025-03-25 |
The Broad Institute, Inc. |
Cas proteins with reduced immunogenicity and methods of screening thereof
|
|
WO2020172343A2
(en)
|
2019-02-19 |
2020-08-27 |
Massachusetts Institute Of Technology |
Methods for treating injuries
|
|
US12215382B2
(en)
|
2019-03-01 |
2025-02-04 |
The General Hospital Corporation |
Liver protective MARC variants and uses thereof
|
|
WO2020186101A1
(en)
|
2019-03-12 |
2020-09-17 |
The Broad Institute, Inc. |
Detection means, compositions and methods for modulating synovial sarcoma cells
|
|
US12419915B2
(en)
|
2019-03-13 |
2025-09-23 |
The Broad Institute, Inc. |
Microglial progenitors for regeneration of functional microglia in the central nervous system and therapeutics uses thereof
|
|
US20220143148A1
(en)
|
2019-03-14 |
2022-05-12 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells
|
|
US12534714B2
(en)
|
2019-03-18 |
2026-01-27 |
The Broad Institute, Inc. |
Type VII CRISPR proteins and systems
|
|
US20220152148A1
(en)
|
2019-03-18 |
2022-05-19 |
The Broad Institute, Inc. |
Modulation of type 2 immunity by targeting clec-2 signaling
|
|
EP3942023A1
(en)
|
2019-03-18 |
2022-01-26 |
The Broad Institute, Inc. |
Compositions and methods for modulating metabolic regulators of t cell pathogenicity
|
|
EP3953484A4
(en)
*
|
2019-04-12 |
2023-04-12 |
University of Massachusetts |
Aav-mediated gene therapy for maple syrup urine disease (msud)
|
|
CA3136735A1
(en)
|
2019-04-15 |
2020-10-22 |
Edigene Inc. |
Methods and compositions for editing rnas
|
|
US12629394B2
(en)
|
2019-04-29 |
2026-05-19 |
The Broad Institute, Inc. |
Atlas of Choroid Plexus cell types and therapeutic and diagnostic uses thereof
|
|
WO2020232271A1
(en)
|
2019-05-14 |
2020-11-19 |
The Broad Institute, Inc. |
Compositions and methods for targeting multinucleated cells
|
|
US20220235340A1
(en)
|
2019-05-20 |
2022-07-28 |
The Broad Institute, Inc. |
Novel crispr-cas systems and uses thereof
|
|
WO2020243371A1
(en)
|
2019-05-28 |
2020-12-03 |
Massachusetts Institute Of Technology |
Methods and compositions for modulating immune responses
|
|
WO2020243661A1
(en)
|
2019-05-31 |
2020-12-03 |
The Broad Institute, Inc. |
Methods for treating metabolic disorders by targeting adcy5
|
|
JP7340372B2
(ja)
*
|
2019-07-11 |
2023-09-07 |
浜松ホトニクス株式会社 |
光活性化アデニル酸シクラーゼ
|
|
AU2020313143B2
(en)
|
2019-07-12 |
2024-04-04 |
Peking University |
Targeted RNA editing by leveraging endogenous adar using engineered RNAs
|
|
US20220282333A1
(en)
|
2019-08-13 |
2022-09-08 |
The General Hospital Corporation |
Methods for predicting outcomes of checkpoint inhibition and treatment thereof
|
|
US12421557B2
(en)
|
2019-08-16 |
2025-09-23 |
The Broad Institute, Inc. |
Methods for predicting outcomes and treating colorectal cancer using a cell atlas
|
|
WO2021046155A1
(en)
|
2019-09-03 |
2021-03-11 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
|
US20230025039A1
(en)
*
|
2019-09-20 |
2023-01-26 |
The Broad Institute, Inc. |
Novel type vi crispr enzymes and systems
|
|
US12297426B2
(en)
|
2019-10-01 |
2025-05-13 |
The Broad Institute, Inc. |
DNA damage response signature guided rational design of CRISPR-based systems and therapies
|
|
US11981922B2
(en)
|
2019-10-03 |
2024-05-14 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment
|
|
US12195725B2
(en)
|
2019-10-03 |
2025-01-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity
|
|
US11793787B2
(en)
|
2019-10-07 |
2023-10-24 |
The Broad Institute, Inc. |
Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
|
|
US12702696B2
(en)
|
2019-10-16 |
2026-08-11 |
Massachusetts Institute Of Technology |
Methods and composition for modulating immune response and immune homeostasis
|
|
US11844800B2
(en)
|
2019-10-30 |
2023-12-19 |
Massachusetts Institute Of Technology |
Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
|
|
US12195723B2
(en)
|
2019-11-08 |
2025-01-14 |
The Broad Institute, Inc. |
Engineered antigen presenting cells and uses thereof
|
|
US11827880B2
(en)
|
2019-12-02 |
2023-11-28 |
Shape Therapeutics Inc. |
Therapeutic editing
|
|
WO2021113390A1
(en)
*
|
2019-12-02 |
2021-06-10 |
Shape Therapeutics Inc. |
Compositions for treatment of diseases
|
|
US12241830B2
(en)
|
2019-12-06 |
2025-03-04 |
Broad Institute, Inc. |
Living biosensors
|
|
US20230039928A1
(en)
*
|
2019-12-23 |
2023-02-09 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease
|
|
AU2020418026A1
(en)
*
|
2019-12-30 |
2022-08-18 |
Edigene Therapeutics (Beijing) Inc. |
Method for treating usher syndrome and composition thereof
|
|
CN113122524B
(zh)
*
|
2019-12-31 |
2023-03-24 |
北京辑因医疗科技有限公司 |
一种靶向编辑rna的新方法
|
|
US20230340537A1
(en)
|
2020-01-17 |
2023-10-26 |
The Broad Institute, Inc. |
Small type ii-d cas proteins and methods of use thereof
|
|
EP4090747A1
(en)
*
|
2020-01-17 |
2022-11-23 |
Sana Biotechnology, Inc. |
Safety switches for regulation of gene expression
|
|
US12165747B2
(en)
|
2020-01-23 |
2024-12-10 |
The Broad Institute, Inc. |
Molecular spatial mapping of metastatic tumor microenvironment
|
|
BR112022015830A2
(pt)
*
|
2020-02-11 |
2022-10-25 |
Pioneer Hi Bred Int |
Métodos e composições para edição multiplexada de genomas de célula vegetal
|
|
CA3178847A1
(en)
*
|
2020-03-19 |
2021-09-23 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Rapid field-deployable detection of sars-cov-2 virus
|
|
US11453907B2
(en)
|
2020-03-23 |
2022-09-27 |
The Broad Institute, Inc. |
Crispr effector system based coronavirus diagnostics
|
|
KR20230035362A
(ko)
*
|
2020-07-06 |
2023-03-13 |
에디진 테라퓨틱스 (베이징) 인크. |
개선된 rna 편집 방법
|
|
CN113897359A
(zh)
*
|
2020-07-06 |
2022-01-07 |
博雅辑因（北京）生物科技有限公司 |
一种改善的rna编辑方法
|
|
CN116194138A
(zh)
|
2020-08-07 |
2023-05-30 |
博德研究所 |
治疗性靶向癌症中经由xpr1:kidins220蛋白质复合物的磷酸盐调节异常
|
|
CN112522264B
(zh)
*
|
2020-11-19 |
2024-03-08 |
南京启真基因工程有限公司 |
一种导致先天性耳聋的CRISPR/Cas9系统及其在制备模型猪核供体细胞中的应用
|
|
KR102685619B1
(ko)
*
|
2020-12-01 |
2024-07-17 |
한양대학교 산학협력단 |
티민-사이토신 서열 특이적 사이토신 교정 활성이 증진된 아데닌 염기교정 유전자가위 및 이의 용도
|
|
CN112553241B
(zh)
*
|
2020-12-10 |
2022-04-01 |
沈阳农业大学 |
OsHOX12蛋白及其编码基因在提高水稻对纹枯病抗性中的应用
|
|
US20240050589A1
(en)
*
|
2020-12-25 |
2024-02-15 |
Shanghai Genemagic Biosciences Co., Ltd. |
Treatment of neurological diseases
|
|
US20240150754A1
(en)
|
2020-12-25 |
2024-05-09 |
Astellas Pharma Inc. |
Guide rna for editing polyadenylation signal sequence of target rna
|
|
GB2622995B
(en)
|
2021-05-27 |
2026-03-25 |
Univ King Abdullah Sci & Tech |
CAS13-based compositions and methods of use thereof
|
|
AU2022284804A1
(en)
|
2021-06-01 |
2023-12-07 |
Arbor Biotechnologies, Inc. |
Gene editing systems comprising a crispr nuclease and uses thereof
|
|
KR20240021893A
(ko)
*
|
2021-06-15 |
2024-02-19 |
메사추세츠 인스티튜트 오브 테크놀로지 |
데아미나제 기반 rna 센서
|
|
CN115678980B
(zh)
*
|
2021-07-22 |
2024-08-27 |
厦门大学 |
Rbm24在长QT间期综合征的诊断和治疗中的用途
|
|
WO2023024504A1
(en)
*
|
2021-08-22 |
2023-03-02 |
Huigene Therapeutics Co., Ltd. |
Crispr-cas13 system for treating sod1-associated diseases
|
|
JP2024541983A
(ja)
*
|
2021-10-29 |
2024-11-13 |
デューク ユニバーシティ |
Ｒｎａプログラム可能な細胞編集のための組成物およびシステム、ならびにそれを作製および使用する方法
|
|
EP4482981A4
(en)
*
|
2022-02-24 |
2026-02-18 |
Univ Leland Stanford Junior |
RNA SENSORS IN LIVING CELLS USING ADAR EDIT FOR DETECTION-RESPONSE APPLICATIONS
|
|
AU2023250649A1
(en)
|
2022-04-04 |
2024-11-14 |
The Regents Of The University Of California |
Genetic complementation compositions and methods
|
|
US20260232844A1
(en)
|
2023-02-15 |
2026-08-13 |
Arbor Biotechnologies, Inc. |
Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
|
|
WO2024192141A1
(en)
|
2023-03-13 |
2024-09-19 |
Dana-Farber Cancer Institute, Inc. |
Treatment of cancers having a drug-resistant mesenchymal cell state
|
|
WO2024197185A1
(en)
|
2023-03-21 |
2024-09-26 |
The Broad Institute, Inc. |
Methods and compositions for dissecting organelle physiology
|
|
WO2024226838A2
(en)
|
2023-04-25 |
2024-10-31 |
The Brigham And Women's Hospital, Inc. |
Treatment of autoimmune diseases having a pathogenic t cell state
|
|
WO2024233949A1
(en)
*
|
2023-05-11 |
2024-11-14 |
Replace Therapeutics, Llc |
Revision of genetic material using direct replacement editing
|
|
WO2024249530A2
(en)
*
|
2023-05-30 |
2024-12-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detecting the activity of rna-modulating drugs using adar editing
|
|
CN117101564A
(zh)
*
|
2023-07-13 |
2023-11-24 |
图维生物医药科技(苏州)有限公司 |
一种生物大分子的制备系统及制备方法
|
|
WO2025049788A1
(en)
|
2023-08-29 |
2025-03-06 |
The Broad Institute, Inc. |
Optical genetic screens of intracellular and intercellular transcriptional circuits with perturb-fish
|
|
CN117210435A
(zh)
*
|
2023-08-29 |
2023-12-12 |
苏州湃芮生物科技有限公司 |
一种用于调控rna甲基化修饰的编辑系统及其应用
|
|
CN116814595B
(zh)
*
|
2023-08-30 |
2023-11-28 |
江苏申基生物科技有限公司 |
一种腺苷脱氨酶突变体及其固定化
|
|
WO2025059533A1
(en)
|
2023-09-13 |
2025-03-20 |
The Broad Institute, Inc. |
Crispr enzymes and systems
|
|
WO2025096916A1
(en)
|
2023-11-03 |
2025-05-08 |
The Broad Institute, Inc. |
Multi-site editing in living cells
|
|
WO2025117544A1
(en)
|
2023-11-29 |
2025-06-05 |
The Broad Institute, Inc. |
Engineered omega guide molecule and iscb compositions, systems, and methods of use thereof
|
|
WO2025129158A1
(en)
|
2023-12-15 |
2025-06-19 |
The Broad Institute, Inc. |
Engineered arc delivery vesicles and uses thereof
|
|
WO2025171210A1
(en)
|
2024-02-09 |
2025-08-14 |
Arbor Biotechnologies, Inc. |
Compositions and methods for gene editing via homology-mediated end joining
|
|
WO2025250808A1
(en)
|
2024-05-29 |
2025-12-04 |
The Brigham And Women’S Hospital, Inc. |
Anti-crispr delivery compositions and methods
|
|
WO2026006436A1
(en)
*
|
2024-06-25 |
2026-01-02 |
Korro Bio, Inc. |
Methods and compositions for the adar-mediated editing of tar dna binding protein 43 kda (tdp43)
|
|
WO2026015829A2
(en)
|
2024-07-12 |
2026-01-15 |
Arbor Biotechnologies, Inc. |
Small reverse transcriptases and gene editing systems comprising such
|
|
WO2026015832A2
(en)
|
2024-07-12 |
2026-01-15 |
Arbor Biotechnologies, Inc. |
Reverse transcriptases and gene editing systems comprising such
|
|
CN119185273B
(zh)
*
|
2024-09-10 |
2025-10-28 |
中国人民解放军空军军医大学 |
Compound C108在制备治疗孤独症谱系障碍药物中的应用
|
|
CN121197415B
(zh)
*
|
2025-11-26 |
2026-02-03 |
山东大学齐鲁医院 |
Cpsf7作为卵巢癌治疗与预后靶点的应用
|